Literature DB >> 11343052

Infantile cholestatic jaundice associated with adult-onset type II citrullinemia.

Y Tazawa1, K Kobayashi, T Ohura, D Abukawa, F Nishinomiya, Y Hosoda, M Yamashita, I Nagata, Y Kono, T Yasuda, N Yamaguchi, T Saheki.   

Abstract

Adult-onset type II citrullinemia, characterized by a liver-specific argininosuccinate synthetase deficiency, is caused by a deficiency of citrin that is encoded by the SLC25A13 gene. Three patients with infantile cholestatic jaundice were found to have mutations of the SLC25A13 gene. Adult-onset type II citrullinemia may be associated with infantile cholestatic disease.

Entities:  

Mesh:

Year:  2001        PMID: 11343052     DOI: 10.1067/mpd.2001.113264

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia.

Authors:  Hai-Yan Fu; Shao-Ren Zhang; Xiao-Hong Wang; Takeyori Saheki; Keiko Kobayashi; Jian-She Wang
Journal:  J Gastroenterol       Date:  2010-10-07       Impact factor: 7.527

2.  Most common SLC25A13 mutation in 400 Chinese infants with intrahepatic cholestasis.

Authors:  Hai-Yan Fu; Shao-Ren Zhang; Hui Yu; Xiao-Hong Wang; Qi-Rong Zhu; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

3.  Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency.

Authors:  K Hayasaka; C Numakura; K Toyota; T Kimura
Journal:  JIMD Rep       Date:  2011-09-06

4.  Different regional distribution of SLC25A13 mutations in Chinese patients with neonatal intrahepatic cholestasis.

Authors:  Rui Chen; Xiao-Hong Wang; Hai-Yan Fu; Shao-Ren Zhang; Kuerbanjiang Abudouxikuer; Takeyori Saheki; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

5.  Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening.

Authors:  E Naito; M Ito; S Matsuura; T Saijo; Y Ogawa; S Kitamura; K Kobayashi; T Saheki; Y Nishimura; N Sakura; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

6.  Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency.

Authors:  Yao Bang Lu; Keiko Kobayashi; Miharu Ushikai; Ayako Tabata; Mikio Iijima; Meng Xian Li; Lei Lei; Kotaro Kawabe; Satoru Taura; Yanling Yang; Tze-Tze Liu; Szu-Hui Chiang; Kwang-Jen Hsiao; Yu-Lung Lau; Lap-Chee Tsui; Dong Hwan Lee; Takeyori Saheki
Journal:  J Hum Genet       Date:  2005-07-30       Impact factor: 3.172

7.  Blood glucose and insulin and correlation of SLC25A13 mutations with biochemical changes in NICCD patients.

Authors:  Chun-Ting Lu; Qi-Ping Shi; Ze-Jian Li; Jiong Li; Lie Feng
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-18

8.  mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

Authors:  Jingsong Cao; Ding An; Mikel Galduroz; Jenny Zhuo; Shi Liang; Marianne Eybye; Andrea Frassetto; Eishi Kuroda; Aki Funahashi; Jordan Santana; Cosmin Mihai; Kerry E Benenato; E Sathyajith Kumarasinghe; Staci Sabnis; Timothy Salerno; Kimberly Coughlan; Edward J Miracco; Becca Levy; Gilles Besin; Joshua Schultz; Christine Lukacs; Lin Guey; Patrick Finn; Tatsuhiko Furukawa; Paloma H Giangrande; Takeyori Saheki; Paolo G V Martini
Journal:  Mol Ther       Date:  2019-04-23       Impact factor: 11.454

9.  Biochemical and molecular characteristics of citrin deficiency in Korean children.

Authors:  Seak Hee Oh; Beom Hee Lee; Gu-Hwan Kim; Jin-Ho Choi; Kyung Mo Kim; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

10.  A novel inborn error of metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency.

Authors:  Toshihiro Ohura; Keiko Kobayashi; Daiki Abukawa; Yusaku Tazawa; Jun-ichiro Aikawa; Osamu Sakamoto; Takeyori Saheki; Kazuie Iinuma
Journal:  Eur J Pediatr       Date:  2003-02-27       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.